| Valleycare Medical Foundation Inc | |
|
5565 W Las Positas Blvd 220 Pleasanton CA 94588-4001 | |
| (925) 416-5450 | |
| (925) 416-6812 |
| Full Name | Valleycare Medical Foundation Inc |
|---|---|
| Speciality | Internal Medicine |
| Location | 5565 W Las Positas Blvd, Pleasanton, California |
| Authorized Official Name and Position | Pamela Marini (COO) |
| Authorized Official Contact | 9254165450 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Valleycare Medical Foundation Inc 5565 W Las Positas Blvd 220 Pleasanton CA 94588-4001 Ph: (925) 416-5450 | Valleycare Medical Foundation Inc 5565 W Las Positas Blvd 220 Pleasanton CA 94588-4001 Ph: (925) 416-5450 |
| NPI Number | 1356598825 |
|---|---|
| Provider Enumeration Date | 08/26/2008 |
| Last Update Date | 12/21/2011 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356598825 | NPI | - | NPPES |
News Archive
Orexigen® Therapeutics, Inc. announced that results from its COR-I trial of Contrave® were published online today in the journal Lancet. COR-I was the largest of the four, 56-week, Phase 3 trials supporting the New Drug Application for Contrave, currently under review by the U.S. Food and Drug Administration. Results show that patients taking Contrave were two to three times more likely to lose at least 5% or 10% of their body weight compared to those taking placebo, on both an intent-to-treat (ITT) and completers basis.
A multicenter research team led by Columbia University Medical Center has discovered a new neurodevelopmental syndrome and the genetic mutations that cause it. The discovery is an important step toward creating targeted therapies for individuals with this syndrome, which causes severe developmental delays, abnormal muscle tone, seizures, and eye complications.
A University of Rochester scientist discovered that the toxins in cigarette smoke wipe out a gene that plays a vital role in protecting the body from the effects of premature aging.
Inhibitex, Inc., today announced its financial results for the third quarter ended September 30, 2009. The Company held cash, cash equivalents and short-term investments of $21.1 million at September 30, 2009, as compared to $33.1 million at December 31, 2008.
Researchers already know that gelatin-covered electrode implants cause less damage to brain tissue than electrodes with no gelatin coating. Researchers at the Neuronano Research Centre at Lund University in Sweden have now shown that microglia, the brain's cleansing cells, and the enzymes that the cells use in the cleaning process, change in the presence of gelatin.
› Verified 8 days ago
Mehrnaz Jamali Md Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 5000 Pleasanton Ave Ste 110, Pleasanton, CA 94566 Phone: 925-484-4406 Fax: 925-484-0346 | |
Axis Community Health Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 4361 Railroad Ave, Pleasanton, CA 94566 Phone: 925-462-1755 | |
Amg Medical Group (de), P.a. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 4900 Hopyard Rd Ste 100, Pleasanton, CA 94588 Phone: 561-901-1741 | |
Axis Community Health Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 4361 Railroad Ave, Pleasanton, CA 94566 Phone: 925-968-9487 | |
Chen Md & Associates Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 4439 Stoneridge Dr, Ste 130, Pleasanton, CA 94588 Phone: 925-461-2840 | |
John Muir Physician Network Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 5860 Owens Dr, Pleasanton, CA 94588 Phone: 925-952-2888 | |
Pleasanton Medical Group Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 5924 Stoneridge Dr Ste 103, Pleasanton, CA 94588 Phone: 925-417-7505 |